While Gossamer Bio Inc has overperformed by 2.95%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GOSS rose by 247.11%, with highs and lows ranging from $3.60 to $0.66, whereas the simple moving average jumped by 81.84% in the last 200 days.
On September 10, 2025, UBS Upgraded Gossamer Bio Inc (NASDAQ: GOSS) to Buy. A report published by Scotiabank on July 14, 2025, Initiated its previous ‘Sector Outperform’ rating for GOSS. Oppenheimer also rated GOSS shares as ‘Outperform’, setting a target price of $9 on the company’s shares in an initiating report dated June 25, 2024. Wedbush Initiated an Outperform rating on April 05, 2024, and assigned a price target of $4. UBS July 27, 2023d its ‘Buy’ rating to ‘Neutral’ for GOSS, as published in its report on July 27, 2023. Guggenheim also rated the stock as ‘Neutral’.
Analysis of Gossamer Bio Inc (GOSS)
Further, the quarter-over-quarter increase in sales is 40.23%, showing a positive trend in the upcoming months.
One of the most important indicators of Gossamer Bio Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -783.37% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.28, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and GOSS is recording 3.73M average volume. On a monthly basis, the volatility of the stock is set at 7.64%, whereas on a weekly basis, it is put at 9.63%, with a gain of 16.30% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.50, showing growth from the present price of $3.14, which can serve as yet another indication of whether GOSS is worth investing in or should be passed over.
How Do You Analyze Gossamer Bio Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.15%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 61.74% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
